IFN Regulatory Factor 8 Restricts the Size of the Marginal Zone and Follicular B Cell Pools

Transcriptional control of marginal zone (MZ) and follicular (FO) B cell development remains incompletely understood. The transcription factor, IFN regulatory factor (IRF)8, is known to play important roles in the differentiation of early B cells. In this article, we demonstrate that IRF8 is also required for normal development of MZ and FO B cells. Mice with a conventional knockout of Irf8 (IRF8−/−) or a point mutation in the IRF association domain of IRF8 had increased numbers of MZ B cells. To determine the B cell-intrinsic effects of IRF8 deficiency, we generated mice with a conditional allele of Irf8 crossed with CD19-Cre mice (designated IRF8-conditional knockout [CKO]). These mice had enlarged MZ and increased numbers of MZ and FO B cells compared with controls. The FO B cells of CKO mice exhibited reduced expression of CD23 and moderately increased expression of CD21. Gene-expression profiling showed that increased B cell production in IRF8-CKO mice was associated with changes in expression of genes involved in regulation of transcription, signaling, and inflammation. Functional studies showed that IRF8-CKO mice generated normal Ab responses to T-independent and T-dependent Ags. Thus, IRF8 controls the expansion and maturation of MZ and FO B cells but has little effect on B cell function.

[1]  S. Pillai,et al.  The follicular versus marginal zone B lymphocyte cell fate decision , 2009, Nature Reviews Immunology.

[2]  Chen-feng Qi,et al.  IFN Regulatory Factor 8 Regulates MDM2 in Germinal Center B Cells1 , 2009, The Journal of Immunology.

[3]  Hongsheng Wang,et al.  IRF8 regulates myeloid and B lymphoid lineage diversification , 2009, Immunologic research.

[4]  M. Raffeld,et al.  Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments , 2009, Immunologic research.

[5]  Chen-feng Qi,et al.  IRF8 regulates B-cell lineage specification, commitment, and differentiation. , 2008, Blood.

[6]  D. Roopenian,et al.  NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas. , 2008, Cancer research.

[7]  G. Gilkeson,et al.  The Transcription Factor Fli-1 Modulates Marginal Zone and Follicular B Cell Development in Mice1 , 2008, The Journal of Immunology.

[8]  P. Lipsky,et al.  Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein , 2008, Journal of Experimental Medicine.

[9]  T. Taniguchi,et al.  The IRF family transcription factors in immunity and oncogenesis. , 2008, Annual review of immunology.

[10]  P. Tailor,et al.  The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse. , 2008, Blood.

[11]  R. Lu,et al.  Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. , 2008, Blood.

[12]  F. Weih,et al.  Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen. , 2007, Blood.

[13]  Lucia Gabriele,et al.  The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. , 2007, Immunity.

[14]  D. Sgroi,et al.  Synergism between NF-κB1/p50 and Notch2 during the Development of Marginal Zone B Lymphocytes1 , 2007, The Journal of Immunology.

[15]  A. Iwama,et al.  Mastermind-1 is required for Notch signal-dependent steps in lymphocyte development in vivo , 2007, Proceedings of the National Academy of Sciences.

[16]  D. Sgroi,et al.  Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B lymphocytes. , 2007, Journal of immunology.

[17]  S. Akira,et al.  Contribution of Receptor Editing to the Antibody Repertoire , 2007 .

[18]  J. Monroe,et al.  Analysis of the Individual Contributions of Igα (CD79a)- and Igβ (CD79b)-Mediated Tonic Signaling for Bone Marrow B Cell Development and Peripheral B Cell Maturation1 , 2006, The Journal of Immunology.

[19]  R. Lu,et al.  IFN Regulatory Factor 4 and 8 Promote Ig Light Chain κ Locus Activation in Pre-B Cell Development1 , 2006, The Journal of Immunology.

[20]  M. Reth,et al.  Testing gene function early in the B cell lineage in mb1-cre mice , 2006, Proceedings of the National Academy of Sciences.

[21]  P. Lipsky,et al.  Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein , 2006, The Journal of experimental medicine.

[22]  Li Wu,et al.  The development of functional B lymphocytes in conditional PU.1 knock-out mice. , 2005, Blood.

[23]  L. Garrett-Sinha,et al.  Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. , 2005, International immunology.

[24]  D. Malo,et al.  A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia–like syndrome in BXH-2 mice , 2005, The Journal of experimental medicine.

[25]  S. Pillai,et al.  Marginal zone B cells. , 2005, Annual review of immunology.

[26]  M. Nussenzweig,et al.  Human Autoantibody Silencing by Immunoglobulin Light Chains , 2004, The Journal of experimental medicine.

[27]  R. Pelanda,et al.  Receptor editing is the main mechanism of B cell tolerance toward membrane antigens , 2004, Nature Immunology.

[28]  N. Tamaoki,et al.  Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo , 2004, Nature Immunology.

[29]  C. Murre,et al.  Receptor Editing and Marginal Zone B Cell Development Are Regulated by the Helix-Loop-Helix Protein, E2A , 2004, The Journal of experimental medicine.

[30]  C. S. Swindle,et al.  Activated Notch2 Potentiates CD8 Lineage Maturation and Promotes the Selective Development of B1 B Cells , 2003, Molecular and Cellular Biology.

[31]  Harinder Singh,et al.  IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. , 2003, Genes & development.

[32]  S. Aizawa,et al.  Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. , 2003, Immunity.

[33]  T. Honjo,et al.  Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. , 2003, Immunity.

[34]  S. Shinton,et al.  Positive Selection of Anti–Thy-1 Autoreactive B-1 Cells and Natural Serum Autoantibody Production Independent from Bone Marrow B Cell Development , 2003, The Journal of experimental medicine.

[35]  T. Manser,et al.  Level of B Cell Antigen Receptor Surface Expression Influences Both Positive and Negative Selection of B Cells During Primary Development1 , 2002, The Journal of Immunology.

[36]  S. Becker-Herman,et al.  Id2 Negatively Regulates B Cell Differentiation in the Spleen1 , 2002, The Journal of Immunology.

[37]  T. Honjo,et al.  Notch–RBP-J signaling is involved in cell fate determination of marginal zone B cells , 2002, Nature Immunology.

[38]  S. Shinton,et al.  Resolution of Three Nonproliferative Immature Splenic B Cell Subsets Reveals Multiple Selection Points During Peripheral B Cell Maturation1 , 2001, The Journal of Immunology.

[39]  W. Pear,et al.  Ligand-independent Signaling Functions for the B Lymphocyte Antigen Receptor and Their Role in Positive Selection during B Lymphopoiesis , 2001, The Journal of experimental medicine.

[40]  F. Weih,et al.  Essential Role of RelB in Germinal Center and Marginal Zone Formation and Proper Expression of Homing Chemokines1 , 2001, The Journal of Immunology.

[41]  Jian Ye,et al.  A VH12 Transgenic Mouse Exhibits Defects in Pre-B Cell Development and Is Unable to Make IgM+ B Cells1 , 2001, The Journal of Immunology.

[42]  S. Pillai,et al.  The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. , 2001, Immunity.

[43]  K. Rajewsky,et al.  Contribution of Receptor Editing to the Antibody Repertoire , 2001, Science.

[44]  K. Ozato,et al.  ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. , 2000, Immunity.

[45]  J. Silver,et al.  Positive selection of natural autoreactive B cells. , 1999, Science.

[46]  P. Sideras,et al.  B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived Signals , 1999, The Journal of experimental medicine.

[47]  M. Retter,et al.  Receptor Editing Occurs Frequently during Normal B Cell Development , 1998, The Journal of experimental medicine.

[48]  B. Morgan,et al.  Aiolos regulates B cell activation and maturation to effector state. , 1998, Immunity.

[49]  K. Rajewsky,et al.  In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death , 1997, Cell.

[50]  J. Waring,et al.  Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene , 1996, Cell.